Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression

BACKGROUND: Atypical antipsychotics such as olanzapine often cause metabolic side effects such as obesity and diabetes, leading to an increased risk of nonalcoholic fatty liver disease. The aim of the present study was to investigate the effects of olanzapine treatment on hepatic lipid metabolism an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chien-Chih, Nakano, Toshiaki, Hsu, Li-Wen, Chu, Chia Yi, Huang, Kuang-Tzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958728/
https://www.ncbi.nlm.nih.gov/pubmed/35355504
http://dx.doi.org/10.2147/NDT.S345046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958728/
https://www.ncbi.nlm.nih.gov/pubmed/35355504
http://dx.doi.org/10.2147/NDT.S345046

Ejemplares similares